Swansea MDT

The Swansea MDT incorporates Singleton Hospital and Morriston Hospital in Swansea http://www.wales.nhs.uk/sitesplus/863/home

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • On-site thoracic surgical team
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
    • Complex vascular reconstruction
    • Distal sacrectomy
    • Extended lymphadenectomy
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 286 2335 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 99 96 86
– Performance status (%) 100 98 89
Patients having major resection: Trust Network National
Number of patients in Audit 216 1436 19631
ASA grade 1 (%) 6 6 9
ASA grade 2 (%) 48 49 53
ASA grade 3 (%) 39 37 31
ASA grade 4+ (%) 6 7 2
ASA grade not recorded (%) 2 1 4
Data completeness of:
7 Audit items for risk-adjustment (%) 90 95 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 286 2335 35779
Seen by Clinical Nurse Specialist (%) 53 88 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 216 1436 19614
Distant metastases (%) 13 8 5
Urgent or emergency surgery (%) 26 18 15
At least 12 lymph nodes excised (%) 90 89 84
Laparoscopic surgery attempted (%) 45 65 72
Risk-adjusted length of stay > 5 days (%) 46 60 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 64 N/A 10747
Adjuvant chemotherapy (%) 61 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 43 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 24 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 49 N/A 4251
Neoadjuvant therapy (%) 46 N/A 33
Circumferential resection margin: Recorded (%) 94 91 89
Circumferential resection margin: Negative (%) 86 86 83
Rectal volume 42 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 174 1145 19644
APER/Hartmanns (%) 44 45 37

Compare trust outcomes